Ontario Researchers Receive Over $39 Million to Support Innovative Research and Technology Development in Natural Resources and Environment Sectors

July 27, 2021

Toronto, July 27, 2021 – Ontario Genomics announces a total investment of over $39 million into the Large Scale Applied Research Program (LSARP) projects from across Ontario that will help address the impact of climate change and pollution. Genome Canada announced funding for eight Canadian projects under the Genomic Solutions for Natural Resources and the Environment…

Read More

Sewage Surveillance: Detecting SARS-CoV-2 Variants in Wastewater across Ontario

June 2, 2021

Ontario Genomics, University of Guelph, University of Ottawa and CHEO announce a game-changing initiative to analyze COVID-19 in wastewater to improve public health response and better understand outbreaks in communities across Ontario. June 2, 2021 – Ontario Genomics, Genome Canada, and Illumina are investing in a first-of-its-kind SARS-CoV-2 wastewater surveillance initiative across Ontario. This cutting-edge…

Read More

Ontario Agriculture & Agri-Food Sector to Benefit from Provincial Investment

May 3, 2021

May 3, 2021 – The Government of Ontario and other partners are investing nearly $27 million into five Ontario Genomics-led and co-led projects in the Large Scale Applied Research Program (LSARP) with applications in the agriculture and agri-food sector. This Genome Canada program supports large-scale genomics applied research projects using genomics approaches to address challenges in Canada’s…

Read More

Major Investment in Genomics Research and Industry to Improve Ontario Healthcare and Environment

May 3, 2021

May 3, 2021 – The Government of Ontario is investing nearly $3 million in three Ontario Genomics-led projects as part of the Genomic Applications Partnership Program (GAPP). This program funds industry-partnered projects that use genomics tools and technologies to address real-world challenges and opportunities with the intent to create numerous downstream impacts for Ontario, such…

Read More

Breakthrough Ontario Projects Receive Over $28 Million to Advance Genomics Innovations

May 3, 2021

May 3, 2021 – The Government of Ontario is investing over $5.7 million in eleven Ontario Genomics-led projects as part of the Bioinformatics and Computational Biology (B/CB) Competition and the Disruptive Innovations in Genomics (DIG) Funding Competition. These programs aim to support transformative, made-in-Ontario genomics technological development to improve human health, agriculture, and natural resources…

Read More

News Release: National Engineering Biology Steering Committee Releases White Paper

November 16, 2020

On November 16, 2020, at the 2020 Canadian Science Policy Conference, Ontario Genomics’ President and CEO, Dr. Bettina Hamelin, announced the launch of an important and comprehensive White Paper: Engineering Biology– A platform technology to fuel multi-sector economic recovery and modernize biomanufacturing in Canada.

Led by Ontario Genomics and written collaboratively by the National Engineering Biology Steering Committee, this paper discusses how engineering biology is a national opportunity to advance Canada’s knowledge-based economy and create high-quality jobs and training opportunities. It will also ensure that Canadian biotechnology companies and manufacturers are competitive in the growing global market.

Read More

Collaborative genomics investments for a healthier Ontario

February 4, 2019

February 4, 2019, Guelph, Ontario – Genomics research is producing dramatic breakthroughs in science, transforming our understanding of the world around us. The results of this research are being used to address important challenges and develop innovative solutions, not just in human health, but across diverse sectors of the economy. Today, the Honourable Kirsty Duncan,…

Read More

Canada and China partnering to develop diagnostics tests for preterm birth

November 30, 2017

BGI and Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, awarded investment from Genome Canada and Ontario Genomics PRESS RELEASE – Shenzhen, China and Toronto, Canada, November 30, 2017 ‒ BGI and the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, today announced the signing of a Memorandum of Understanding (MOU) outlining their intention to…

Read More